Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Our e-services for applications, projects and assessments close on Thursday 25 April at 4:30pm because of system upgrades. We expect to open them again on Friday 26 April at 8am the latest.

SwissNordicBio 2019

Reference number
Coordinator VectorizeMove AB
Funding from Vinnova SEK 8 333
Project duration February 2019 - March 2019
Status Completed

Purpose and goal

The project has led to attending the SwissNordicBio 2019 and get an in-depth perspective on how pharma companies perceive medtech innovations, especially in terms of early collaborations. It has also led to kick starting discussions with other medtech companies towards strategic collaborations, geographical business opportunities, insights on raising investment rounds and EU funding opportunities.

Expected results and effects

The visit has led to high-level networking, insights into European medtech markets and EU funding opportunities.

Planned approach and implementation

Matchmaking meetings Networking meetings Attending keynotes and company pitches

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 1 March 2019

Reference number 2019-01346

Page statistics